Clinical Trials Browser

Phase NA × Hematologic Neoplasms × gilteritinib × Clear all

NCT06992934 2025-08-03

TARGETALLO

Phase NA Not yet recruiting

Other hematologic neoplasm

Hematologic Neoplasms